| AFICX | VTSMX | AFICX / VTSMX | |
| Total Expense Ratio | 1.33 | 0.06 | 2,217% |
| Annual Report Gross Expense Ratio | 1.33 | 0.06 | 2,217% |
| Fund Existence | 25 years | 34 years | - |
| Gain YTD | 11.122 | 10.110 | 110% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 183B | 2.31T | 8% |
| Annual Yield % from dividends | 0.00 | 0.99 | - |
| Returns for 1 year | 16.42 | 20.87 | 79% |
| Returns for 3 years | 51.34 | 67.54 | 76% |
| Returns for 5 years | 33.94 | 64.50 | 53% |
| Returns for 10 years | 98.44 | 256.48 | 38% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BHCFX | 22.33 | 0.44 | +2.01% |
| Baron Health Care Retail | |||
| JFCCX | 31.98 | 0.27 | +0.85% |
| JHancock Fundamental All Cap Core C | |||
| VLIFX | 34.58 | 0.27 | +0.79% |
| Value Line Mid Cap Focused Inv | |||
| QKACX | 55.49 | 0.26 | +0.47% |
| Federated Hermes MDT All Cap Core R6 | |||
| TRSAX | 103.68 | -1.08 | -1.03% |
| T. Rowe Price Growth Stock Adv | |||